Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 1.000 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.527 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.515 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.511 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.510 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.508 | |
| 3cok | ANP | Serine/threonine-protein kinase PLK4 | 2.7.11.21 | 0.504 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.504 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.503 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.502 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.501 | |
| 1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.500 | |
| 4bbe | 3O4 | Tyrosine-protein kinase JAK2 | / | 0.500 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.499 | |
| 4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.497 | |
| 4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.497 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.496 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.496 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.495 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.492 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.492 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.491 | |
| 2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.490 | |
| 3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.490 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.490 | |
| 3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.489 | |
| 4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.489 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.489 | |
| 5ap5 | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.489 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.488 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.488 | |
| 2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.487 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.486 | |
| 2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.484 | |
| 2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.484 | |
| 4c4f | 7CE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.484 | |
| 2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.483 | |
| 2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.483 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.482 | |
| 4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.482 | |
| 2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.481 | |
| 2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.481 | |
| 4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.481 | |
| 4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.481 | |
| 4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.480 | |
| 3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.479 | |
| 4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.479 | |
| 3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.477 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.477 | |
| 4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.476 | |
| 4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.476 | |
| 3t8o | ATP | Rhodopsin kinase | / | 0.475 | |
| 4b8m | VX6 | Aurora kinase B-A | 2.7.11.1 | 0.475 | |
| 4i0r | 1B4 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.475 | |
| 4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.475 | |
| 4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.475 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.474 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.474 | |
| 4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.474 | |
| 4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.474 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.474 | |
| 2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.473 | |
| 2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.473 | |
| 2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.473 | |
| 3w2o | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.473 | |
| 4c57 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.473 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.473 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.471 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.471 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.471 | |
| 4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.471 | |
| 3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.470 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.470 | |
| 4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.470 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.469 | |
| 4c58 | 824 | Cyclin-G-associated kinase | 2.7.11.1 | 0.469 | |
| 4jbp | YPH | Aurora kinase A | 2.7.11.1 | 0.469 | |
| 4izy | 1J2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.468 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.467 | |
| 2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.467 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.467 | |
| 3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.467 | |
| 4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.467 | |
| 1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.466 | |
| 1u54 | ACP | Activated CDC42 kinase 1 | / | 0.466 | |
| 4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.466 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.465 | |
| 2c7x | NRB | Cytochrome P450 monooxygenase PikC | / | 0.465 | |
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.465 | |
| 2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.465 | |
| 3gc8 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.465 | |
| 3igo | ANP | Calmodulin-domain protein kinase 1, putative | / | 0.465 | |
| 3l08 | ZIG | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.465 | |
| 4c4i | X20 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.465 | |
| 4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.465 | |
| 4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.465 | |
| 4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.465 | |
| 1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.464 | |
| 2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.464 | |
| 3d7t | STU | Tyrosine-protein kinase CSK | / | 0.464 | |
| 4eym | 0RX | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.464 | |
| 4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.464 | |
| 4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.464 | |
| 5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.464 | |
| 2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.463 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.463 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.463 | |
| 4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.463 | |
| 5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.463 | |
| 4xlv | ACP | Insulin receptor | 2.7.10.1 | 0.462 | |
| 2pzp | ACP | Fibroblast growth factor receptor 2 | / | 0.461 | |
| 3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.461 | |
| 3f5p | 741 | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.461 | |
| 3w1f | 1O5 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.461 | |
| 2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.460 | |
| 2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.460 | |
| 3e5a | VX6 | Aurora kinase A | 2.7.11.1 | 0.460 | |
| 3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.460 | |
| 2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.459 | |
| 2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.459 | |
| 3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.459 | |
| 3zk5 | Z18 | Cytochrome P450 monooxygenase PikC | / | 0.459 | |
| 4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.459 | |
| 4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
| 2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.458 | |
| 2yiq | YIQ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.458 | |
| 2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.458 | |
| 4d0l | 093 | Phosphatidylinositol 4-kinase beta | 2.7.1.67 | 0.458 | |
| 4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.458 | |
| 2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.457 | |
| 4a4v | YFD | Peroxisome proliferator-activated receptor gamma | / | 0.457 | |
| 4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.457 | |
| 4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.457 | |
| 4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.457 | |
| 4l3l | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.457 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.457 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.457 | |
| 2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.456 | |
| 2o0u | C0M | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.456 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.456 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.456 | |
| 4joa | 3DK | ALK tyrosine kinase receptor | 2.7.10.1 | 0.456 | |
| 2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.455 | |
| 2y46 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.455 | |
| 4o0w | ADN | Aurora kinase A | 2.7.11.1 | 0.455 | |
| 4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.455 | |
| 5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.455 | |
| 1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.454 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.454 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.454 | |
| 3oro | AGS | Serine/threonine protein kinase | / | 0.454 | |
| 3th8 | TH9 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.454 | |
| 4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.454 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.454 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.454 | |
| 2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.453 | |
| 2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.453 | |
| 3h0a | D30 | Peroxisome proliferator-activated receptor gamma | / | 0.453 | |
| 3lij | ANP | Calcium/calmodulin dependent protein kinase with a kinase domain and 4 calmodulin like EF hands | / | 0.453 | |
| 3nwq | 2NC | Gag-Pol polyprotein | 3.4.23.16 | 0.453 | |
| 3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.453 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.453 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.453 | |
| 1sn5 | T3 | Transthyretin | / | 0.452 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.452 | |
| 3qk0 | QK0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.452 | |
| 4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.452 | |
| 4l42 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.452 | |
| 4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.452 | |
| 4xhg | ADP | Uncharacterized protein | / | 0.452 | |
| 2e9c | B75 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.451 | |
| 2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.451 | |
| 3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.451 | |
| 4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.451 | |
| 4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.451 | |
| 4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.451 | |
| 1wvx | BD4 | Death-associated protein kinase 1 | 2.7.11.1 | 0.450 | |
| 2b1p | AIZ | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.450 | |
| 2pz5 | ACP | Fibroblast growth factor receptor 2 | / | 0.450 | |
| 2wti | WTI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.450 | |
| 4l9q | 9TP | Serum albumin | / | 0.450 | |
| 4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.450 | |
| 2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.449 | |
| 2j0d | ERY | Cytochrome P450 3A4 | / | 0.449 | |
| 2j0k | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.449 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.449 | |
| 3nwy | GTP | Uridylate kinase | / | 0.449 | |
| 4c3p | ACP | Aurora kinase A | 2.7.11.1 | 0.449 | |
| 4nb6 | 444 | Nuclear receptor ROR-gamma | / | 0.449 | |
| 2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.448 | |
| 2ycf | YCF | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.448 | |
| 3fzp | AGS | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.448 | |
| 3we4 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.448 | |
| 4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.448 | |
| 4hgt | 15G | Casein kinase I isoform delta | 2.7.11.1 | 0.448 | |
| 5auw | QUE | Death-associated protein kinase 1 | 2.7.11.1 | 0.448 | |
| 1ie4 | T44 | Transthyretin | / | 0.447 | |
| 1w84 | L12 | Mitogen-activated protein kinase 14 | / | 0.447 | |
| 2ijm | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.447 | |
| 2o2u | 738 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.447 | |
| 2vww | 7X2 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.447 | |
| 2y03 | Y01 | Beta-1 adrenergic receptor | / | 0.447 | |
| 3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.447 | |
| 3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.447 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.447 | |
| 4z34 | ON7 | Lysophosphatidic acid receptor 1 | / | 0.447 | |
| 1k6p | XN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.446 | |
| 2c6h | PXI | Cytochrome P450 monooxygenase PikC | / | 0.446 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 2hw2 | RFP | Rifampin ADP-ribosyl transferase | / | 0.446 | |
| 2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.446 | |
| 2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.446 | |
| 2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.446 | |
| 2vzm | NRB | Cytochrome P450 monooxygenase PikC | / | 0.446 | |
| 3c4x | ATP | Rhodopsin kinase | / | 0.446 | |
| 3icr | COA | Coenzyme A disulfide reductase | / | 0.446 | |
| 3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.446 | |
| 3ruk | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.446 | |
| 4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.446 | |
| 4dfl | 0K0 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.446 | |
| 4g17 | 0VN | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.446 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.446 | |
| 1pme | SB2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.445 | |
| 1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.445 | |
| 1zrz | BI1 | Protein kinase C iota type | 2.7.11.13 | 0.445 | |
| 2ca0 | PXI | Cytochrome P450 monooxygenase PikC | / | 0.445 | |
| 2cke | IQU | Death-associated protein kinase 2 | / | 0.445 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.445 | |
| 2w1f | L0F | Aurora kinase A | 2.7.11.1 | 0.445 | |
| 2xbj | XBJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.445 | |
| 3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.445 | |
| 3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.445 | |
| 3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
| 3qaq | QAQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.445 | |
| 3t2z | FAD | Sulfide-quinone reductase | / | 0.445 | |
| 4b7s | QLE | Cytochrome P450 monooxygenase PikC | / | 0.445 | |
| 4wlo | NAI | Malate dehydrogenase, mitochondrial | 1.1.1.37 | 0.445 | |
| 2aid | THK | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
| 2hw1 | ANP | Ketohexokinase | / | 0.444 | |
| 2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
| 3fpb | CZA | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.444 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.444 | |
| 4a4w | YFB | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
| 4bkz | 1WS | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.444 | |
| 4c59 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.444 | |
| 4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
| 4o0u | ADN | Aurora kinase A | 2.7.11.1 | 0.444 | |
| 4q72 | FAD | Bifunctional protein PutA | / | 0.444 | |
| 4wbo | ANW | Rhodopsin kinase | / | 0.444 | |
| 1yvj | 4ST | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.443 | |
| 2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.443 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.443 | |
| 2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.443 | |
| 3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.443 | |
| 3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.443 | |
| 3ma3 | 01I | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.443 | |
| 3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.443 | |
| 4cy8 | FDA | 2-hydroxybiphenyl-3-monooxygenase | / | 0.443 | |
| 4ft9 | H4K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 1s9j | BBM | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.442 | |
| 2qa1 | FAD | PgaE | / | 0.442 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.442 | |
| 3cyl | VIT | Basic phospholipase A2 homolog piratoxin-2 | / | 0.442 | |
| 4fjy | FJY | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.442 | |
| 4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 4ftk | H9K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.442 | |
| 4fyn | 0VE | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.442 | |
| 4kb8 | 1QN | Casein kinase I isoform delta | 2.7.11.1 | 0.442 | |
| 4l9i | 8PR | Rhodopsin kinase | / | 0.442 | |
| 1ee0 | CAA | 2-pyrone synthase | / | 0.441 | |
| 1guf | NDP | Enoyl-[acyl-carrier-protein] reductase 1, mitochondrial | 1.3.1.10 | 0.441 | |
| 2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
| 2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.441 | |
| 2q0b | ACP | Fibroblast growth factor receptor 2 | / | 0.441 | |
| 2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.441 | |
| 2w9s | TOP | Dihydrofolate reductase type 1 from Tn4003 | 1.5.1.3 | 0.441 | |
| 3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.441 | |
| 3kpk | FAD | Sulfide-quinone reductase | / | 0.441 | |
| 3lj3 | WYE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.441 | |
| 3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.441 | |
| 3orz | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
| 3zc6 | VFC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.441 | |
| 4eut | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.441 | |
| 4jrn | ANP | Rhoptry kinase family protein | / | 0.441 | |
| 5a27 | MYA | Glycylpeptide N-tetradecanoyltransferase | / | 0.441 | |
| 1jvs | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.440 | |
| 1xl2 | 189 | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
| 2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.440 | |
| 2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.440 | |
| 3ggg | NAD | Prephenate dehydrogenase | / | 0.440 | |
| 3ml9 | ML9 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
| 3uo5 | 0BX | Aurora kinase A | 2.7.11.1 | 0.440 | |
| 3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.440 | |
| 4aw3 | MYV | Mycinamicin IV hydroxylase/epoxidase | / | 0.440 | |
| 4b7d | QLE | Cytochrome P450 monooxygenase PikC | / | 0.440 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.440 | |
| 4ia7 | BIV | Vitamin D3 receptor A | / | 0.440 | |
| 4ysj | ADP | Calmodulin-like domain protein kinase | / | 0.440 |